Recall archive / FDA company announcement
Silintan: Dietary supplement capsules marketed for relief of joint and body aches — FDA announcement Jan 9, 2026
Published notice; closure not supplied
A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.
Source date Jan 9, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Dietary supplement capsules marketed for relief of joint and body aches
- Reason
- Unapproved new drug found to contain undeclared meloxicam
- Classification
- Not supplied
- Recalling firm
- Anthony Trinh, 123Herbals LLC
- Quantity
- Not supplied
- Agency-reported status
- Company recall announcement
- Source record identifier
- 137a4ca4c76723d6
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | The tainted Silintan is marketed as a dietary supplement for relief of joint and body aches and is packaged in 25-count plastic bottles with blue labels (see labels below). The affected Silintan capsules include all lot numbers within expiry. Silintan capsules were distributed nationwide online at 123herbals.com |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Not supplied
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Fda listing date
- Jan 9, 2026
- Company announcement date
- Jan 7, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.